Literature DB >> 26831938

Mapping time-course mitochondrial adaptations in the kidney in experimental diabetes.

Melinda T Coughlan1, Tuong-Vi Nguyen2, Sally A Penfold2, Gavin C Higgins3, Vicki Thallas-Bonke2, Sih Min Tan4, Nicole J Van Bergen5, Karly C Sourris4, Brooke E Harcourt6, David R Thorburn6, Ian A Trounce5, Mark E Cooper4, Josephine M Forbes7.   

Abstract

Oxidative phosphorylation (OXPHOS) drives ATP production by mitochondria, which are dynamic organelles, constantly fusing and dividing to maintain kidney homoeostasis. In diabetic kidney disease (DKD), mitochondria appear dysfunctional, but the temporal development of diabetes-induced adaptations in mitochondrial structure and bioenergetics have not been previously documented. In the present study, we map the changes in mitochondrial dynamics and function in rat kidney mitochondria at 4, 8, 16 and 32 weeks of diabetes. Our data reveal that changes in mitochondrial bioenergetics and dynamics precede the development of albuminuria and renal histological changes. Specifically, in early diabetes (4 weeks), a decrease in ATP content and mitochondrial fragmentation within proximal tubule epithelial cells (PTECs) of diabetic kidneys were clearly apparent, but no changes in urinary albumin excretion or glomerular morphology were evident at this time. By 8 weeks of diabetes, there was increased capacity for mitochondrial permeability transition (mPT) by pore opening, which persisted over time and correlated with mitochondrial hydrogen peroxide (H2O2) generation and glomerular damage. Late in diabetes, by week 16, tubular damage was evident with increased urinary kidney injury molecule-1 (KIM-1) excretion, where an increase in the Complex I-linked oxygen consumption rate (OCR), in the context of a decrease in kidney ATP, indicated mitochondrial uncoupling. Taken together, these data show that changes in mitochondrial bioenergetics and dynamics may precede the development of the renal lesion in diabetes, and this supports the hypothesis that mitochondrial dysfunction is a primary cause of DKD.
© 2016 Authors; published by Portland Press Limited.

Entities:  

Keywords:  diabetic nephropathy; experimental diabetes; kidney disease; mitochondria

Mesh:

Substances:

Year:  2016        PMID: 26831938     DOI: 10.1042/CS20150838

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  40 in total

Review 1.  Mitochondrial energetics in the kidney.

Authors:  Pallavi Bhargava; Rick G Schnellmann
Journal:  Nat Rev Nephrol       Date:  2017-08-14       Impact factor: 28.314

Review 2.  Vascular complications in diabetes: old messages, new thoughts.

Authors:  Josephine M Forbes; Amelia K Fotheringham
Journal:  Diabetologia       Date:  2017-07-19       Impact factor: 10.122

3.  Mapping Adverse Outcome Pathways for Kidney Injury as a Basis for the Development of Mechanism-Based Animal-Sparing Approaches to Assessment of Nephrotoxicity.

Authors:  Angela Mally; Sebastian Jarzina
Journal:  Front Toxicol       Date:  2022-06-15

Review 4.  Mitochondria-Associated Endoplasmic Reticulum Membranes (MAMs) and Their Prospective Roles in Kidney Disease.

Authors:  Peng Gao; Wenxia Yang; Lin Sun
Journal:  Oxid Med Cell Longev       Date:  2020-09-03       Impact factor: 6.543

Review 5.  Acute Kidney Injury and Progression of Diabetic Kidney Disease.

Authors:  Samuel Mon-Wei Yu; Joseph V Bonventre
Journal:  Adv Chronic Kidney Dis       Date:  2018-03       Impact factor: 3.620

Review 6.  Mitochondrial dysfunction in diabetic kidney disease.

Authors:  Josephine M Forbes; David R Thorburn
Journal:  Nat Rev Nephrol       Date:  2018-02-19       Impact factor: 28.314

7.  A model of mitochondrial O2 consumption and ATP generation in rat proximal tubule cells.

Authors:  Aurélie Edwards; Fredrik Palm; Anita T Layton
Journal:  Am J Physiol Renal Physiol       Date:  2019-12-02

8.  Targeting Methylglyoxal in Diabetic Kidney Disease Using the Mitochondria-Targeted Compound MitoGamide.

Authors:  Sih Min Tan; Runa S J Lindblom; Mark Ziemann; Adrienne Laskowski; Cesare Granata; Matthew Snelson; Vicki Thallas-Bonke; Assam El-Osta; Carlos D Baeza-Garza; Stuart T Caldwell; Richard C Hartley; Thomas Krieg; Mark E Cooper; Michael P Murphy; Melinda T Coughlan
Journal:  Nutrients       Date:  2021-04-25       Impact factor: 6.706

Review 9.  Shaping Up Mitochondria in Diabetic Nephropathy.

Authors:  Koki Mise; Daniel L Galvan; Farhad R Danesh
Journal:  Kidney360       Date:  2020-09-24

10.  Nephroprotective Effects of Tetramethylpyrazine Nitrone TBN in Diabetic Kidney Disease.

Authors:  Mei Jing; Yun Cen; Fangfang Gao; Ting Wang; Jinxin Jiang; Qianqian Jian; Liangmiao Wu; Baojian Guo; Fangcheng Luo; Gaoxiao Zhang; Ying Wang; Lipeng Xu; Zaijun Zhang; Yewei Sun; Yuqiang Wang
Journal:  Front Pharmacol       Date:  2021-06-24       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.